Steady growth in world cardiac diagnostics market
This article was originally published in Clinica
The world market for cardiac diagnostic and monitoring equipment is set to grow from $509 million in 1995 to $647 million by 2001, says a new report from Frost & Sullivan. Cardiac telemetry systems will increase their share of the market from 33% in 1994 to 40% in 2001 while standard ECGs will slide from 38% to 34% and long-term ECGs from 29% to 25% over the same period. Compound annual growth for the sector will be 3.9% to 2001.
You may also be interested in...
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.